upCheck is a web-based tool used globally to screen for duplicate
patients in clinical trials across studies, sponsors and therapeutic areas.
Duplicate enrollment harms both patients and studies.In many therapeutic
areas even a small number of duplicate patients can lead to a negative or
failed trial. In addition enrolling duplicate patients can result in a
misattributed serious adverse event.
DupCheck is part of NEWMEDS an international consortium of scientists
that has launched one of the largest ever research academic-industry
collaboration projects to find new methods for the development of drugs.
NEWMEDS brings together top scientists from academic institutions with a
wide range of expertise, and partners them with nearly all major
biopharmaceutical companies. NEWMEDS ultimate goal is to develop new
approaches for shorter and more efficient trials of new medications.
DupCheck provides sites and sponsors with real time information on
attempted duplicate enrollment at time of screening. DupCheck can also
screen for previous participation in a trial of investigational drug.
DupCheck can be linked to existing electronic data capture
systems—eliminating additional data entry—and run in the background, analogues
to an anti-virus.
DupCheck is available for integration with:
Trident IRT by Bioclinica
ClinSpark, Web-base phase 1 eSource/EDC system supporting traditional browsers
and mobile devices.
Y-Prime IRT and eCOA systems.
Veracity VLIRT system
MedSciNet EDC and IVRS. MedSciNet specializes in designing and developing web applications and online database systems for medical research. MedSciNet is an international company with its roots at the Karolinska Institute (Sweden), specializing in web applications and online database systems for clinical trials, medical registries and biobanks.
Target e*CRF, the fully integrated paperless clinical trial
solution from Target Health
NEFORM by NESS, the only eSource, mobile, data capture system,
that collects clinical eCRF, site/home ePRO and rater evaluation data on Apple
IOS, Android™ and Windows tablets, smartphones and PCs with or without an
DupCheck provides sponsor with one click real time data on screening
DupCheck is HIPAA and
European Data Protection Regulation compliant. No identifiable patient or
sponsor data is transmitted, stored or shared. DupCheck was given a
favorable Qualification Advice review by the European Medicines Agency and the
FDA has stated that DupChecking is advisable.
DupCheck is an ACRES ally
For a link to a 6 minute video demonstrating DupCheck or
for more information, sponsors, investigators and regulators please contact us
Jonathan Rabinowitz, PhD is the founding director of
DupCheck. He is the Elie Wiesel
Professor at Bar Ilan University and a visiting professor at Mount Sinai School
of Medicine in New York. His research
focuses on improving efficiency of clinical trials. He has over 25 years of experience in
managing and analyzing large data sets and in developing and implementing
statistical algorithms in pharmaceutical, services and epidemiological datasets. He is the academic lead of
the Advanced Data
Analysis Techniques group at IMI/EFPIA sponsored NEMWEDS, one of the largest
ever research academic-industry collaboration projects directed at finding
new methods for drug development. He did
doctoral training in Statistics at Bar Ilan University and in Social Welfare at
Yeshiva University. He serves on
advisory groups at FDA and EMA. He is a
member of the American College of Neuropsychopharmacology. He is on the Executive Committee of
International Society for CNS Clinical
Trials and Methodology and also serves as co-chair of the working group on
consistency in measurement. He has
served as a member of the DIA Scientific Working Group on Missing Data in
Clinical Trials. He has over 170
David Feigenbaum, DBA holds a doctorate in Decision Sciences from the
Graduate School of Management at Kent State University and a BS and MBA from
Case Western Reserve University. He has
served in various senior management positions at American Greetings, Chessie
Systems and Arthur D. Little and has worked as an independent consultant. He has served as Adjunct Associate
the University of Maryland College Park.
Information Technology (IT) Team Leader
Gregory Kogan, has over 18 years of software
development and project management experience.
He held developer, team and project leader positions at Nareos, Samsung
Telecom Research Israel, Harel Insurance Company, First International Bank of
Israel and IBM Israel Software Lab. He
has a B.Sc. in Computer Science from Bar Ilan University. Mr. Kogan has deep pockets of expertise in
database architecture, administration, design, web development and system
Gross, Kleinhendler, Hodak, Halevy, Greenberg & Co.